what is a glp 1 antagonist GLP-1 Agonists - it? Frontiers | GLP-1 Receptor Agonists:

One day early

Studies prove that people sleeping fewer than 67 hours per night experience 30% greater weight rebound after stopping GLP-1 therapy

Novo Nordisk announced FDA acceptance of their New Drug Application (NDA) for a 25 mg oral version of Wegovy for two new indications: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of major adverse cardiac events (MACE) in adults with overweight or obesity and established CVD

Additional considerations include diabetic retinopathy status (semaglutide may worsen retinopathy in some patients with pre-existing disease, particularly with rapid A1c improvement), history of pancreatitis (use GLP-1 agents with caution), and upcoming surgical procedures (discuss with your surgical/anesthesia team due to effects on gastric emptying)

Some providers do prescribe shortened intervals for specific clinical scenarios, but this should be a medical decision, not a personal one

Editor MeilW